| 恒瑞医药财务报表 |
评论“恒瑞医药” |
|
|
|
|
| 项目 |
2001年 |
2000年 |
1999年 |
| 一、主营业务收入 |
634,268,928.00 |
484,707,200.00 |
413,929,920.00 |
| 减：折扣与折让 |
0.00 |
|
|
| 主营业务收入净额 |
634,268,928.00 |
484,707,200.00 |
413,929,920.00 |
| 减：主营业务成本 |
255,391,936.00 |
226,709,344.00 |
216,243,936.00 |
| 主营业务税金及附加 |
7,807,359.50 |
4,994,224.00 |
4,173,787.25 |
| 二、主营业务利润 |
371,069,664.00 |
253,003,616.00 |
193,512,208.00 |
| 加：其它业务利润 |
3,253,309.00 |
4,054,610.00 |
533,047.69 |
| 减：存货跌价损失 |
0.00 |
62,130.49 |
317,800.00 |
| 营业费用 |
168,590,032.00 |
111,794,600.00 |
66,931,168.00 |
| 管理费用 |
107,044,000.00 |
65,038,216.00 |
57,801,712.00 |
| 财务费用 |
10,713,573.00 |
5,945,790.00 |
6,737,560.50 |
| 销售费用 |
|
|
|
| 三、营业利润 |
87,975,360.00 |
74,217,488.00 |
62,257,016.00 |
| 加：投资收益 |
3,254,434.00 |
-865,935.81 |
303,750.00 |
| 补贴收入 |
1,064,639.00 |
2,117,458.25 |
1,072,516.25 |
| 营业外收入 |
8,395,417.00 |
8,809,889.00 |
840,952.69 |
| 减：营业外支出 |
3,024,389.50 |
2,391,685.25 |
1,763,244.62 |
| 四、利润总额 |
97,665,464.00 |
81,887,216.00 |
62,710,988.00 |
| 减：所得税 |
16,261,563.00 |
16,349,680.00 |
11,061,314.00 |
| 减：少数股东损益 |
248,817.38 |
266,150.53 |
317,207.44 |
| 加：财政返还（含所得税返还） |
|
|
|
| 五、净利润 |
81,155,080.00 |
65,271,388.00 |
51,332,468.00 |
| 加：年初未分配利润 |
64,945,000.00 |
27,024,264.00 |
57,377,196.00 |
| 盈余公积金转入 |
6,595,864.00 |
|
|
| 六、可供分配的利润 |
152,695,952.00 |
92,295,648.00 |
108,709,664.00 |
| 减：提取法定公积金 |
8,601,211.00 |
7,032,824.50 |
5,735,941.00 |
| 提取法定公益金 |
8,601,211.00 |
7,032,824.50 |
5,735,941.00 |
| 七、可供股东分配的利润 |
135,493,520.00 |
78,230,000.00 |
97,237,784.00 |
| 减：应付优先股股利 |
0.00 |
|
|
| 提取任意盈余公积 |
|
|
|
| 提取任意公积 |
0.00 |
|
|
| 应付普通股股利 |
10,628,000.00 |
13,285,000.00 |
30,640,500.00 |
| 转做股本的普通股股利 |
39,855,000.00 |
|
30,950,000.00 |
|
